SCHEMBL14770641

SCHEMBL14770641

c1ccc2c(c1)oc1ccc(-c3ccnc(-c4cc(-c5ccc6oc7ccc(-n8c9ccccc9c9ccccc98)cc7c6c5)ccn4)c3)cc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.39
MAPT P10636 2/20 0.39
KDM4E B2RXH2 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
RAB9A P51151 1/20 0.36
KMT2A Q03164 1/20 0.36
CHEK2 O96017 1/20 0.34
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PTPN1 P18031 2/20 0.34
AHR P35869 1/20 0.33
PRKDC P78527 1/20 0.33
PLA2G2A P14555 2/20 0.33
PLA2G4A P47712 2/20 0.33
CASP3 P42574 1/20 0.32
SENP7 Q9BQF6 1/20 0.32
SENP6 Q9GZR1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14770639 0.95 KDM4E (0.34) NPC1MAPTKDM4ESMN1; SMN2MEN1
SCHEMBL10041344 0.94 KDM4E (0.35) NPC1MAPTKDM4ESMN1; SMN2MEN1
SCHEMBL14770644 0.91 ALOX5 (0.44) NPC1MAPTPTPN1PRKDCPTPRF
SCHEMBL15780988 0.88 KDM4E (0.45) NPC1MAPTKDM4ESMN1; SMN2MEN1
SCHEMBL10348589 0.88 KDM4E (0.45) NPC1MAPTKDM4ESMN1; SMN2MEN1
SCHEMBL14770643 0.88 NPC1 (0.32) NPC1MAPTPTPN1PTPRFPTPN2
SCHEMBL14770703 0.88 KDM4E (0.36) NPC1MAPTKDM4ESMN1; SMN2MEN1
SCHEMBL12455148 0.88 PLA2G2A (0.37) NPC1MAPTKDM4ESMN1; SMN2MEN1
SCHEMBL14770705 0.86 PDE4A (0.35) NPC1MAPTKDM4ESMN1; SMN2MEN1
SCHEMBL18265969 0.86 KDM4E (0.42) NPC1MAPTKDM4ESMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9604972-B2 Nitrogen-containing heteroaromatic ring compound IDEMITSU KOSAN CO., LTD. (JP) 2017-03-28 US disclosed
US-9604972-B2 Nitrogen-containing heteroaromatic ring compound IDEMITSU KOSAN CO., LTD. (JP) 2017-03-28 US disclosed
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2013-03-14 US disclosed
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2013-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND TDO2, AHR, NOC2L NPC1 3134/4885MAPT 2242/4885KDM4E 1763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.